End-of-day quote
Thailand S.E.
18:00:00 2024-05-09 EDT
|
5-day change
|
1st Jan Change
|
7.85
THB
|
+0.64%
|
|
-1.26%
|
+5.37%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
3,567
|
3,538
|
4,166
|
6,391
|
5,107
|
4,251
|
Enterprise Value (EV)
1 |
3,860
|
3,785
|
4,477
|
5,516
|
4,231
|
3,555
|
P/E ratio
|
20.2
x
|
17.7
x
|
22.4
x
|
5.09
x
|
7.33
x
|
15
x
|
Yield
|
1.92%
|
2.26%
|
1.71%
|
4.46%
|
5.03%
|
2.68%
|
Capitalization / Revenue
|
1.58
x
|
1.41
x
|
1.82
x
|
1.35
x
|
1.39
x
|
1.54
x
|
EV / Revenue
|
1.71
x
|
1.51
x
|
1.95
x
|
1.17
x
|
1.16
x
|
1.29
x
|
EV / EBITDA
|
10.4
x
|
9.12
x
|
11.7
x
|
3.19
x
|
4.15
x
|
6.98
x
|
EV / FCF
|
-68.5
x
|
45.6
x
|
617
x
|
5.81
x
|
23.1
x
|
183
x
|
FCF Yield
|
-1.46%
|
2.19%
|
0.16%
|
17.2%
|
4.33%
|
0.55%
|
Price to Book
|
3.05
x
|
2.73
x
|
2.97
x
|
2.47
x
|
1.7
x
|
1.4
x
|
Nbr of stocks (in thousands)
|
570,665
|
570,665
|
570,665
|
570,665
|
570,665
|
570,665
|
Reference price
2 |
6.250
|
6.200
|
7.300
|
11.20
|
8.950
|
7.450
|
Announcement Date
|
19-02-25
|
20-02-27
|
21-02-22
|
22-02-24
|
23-02-27
|
24-02-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
2,259
|
2,503
|
2,290
|
4,730
|
3,662
|
2,761
|
EBITDA
1 |
369.4
|
414.9
|
382.9
|
1,731
|
1,020
|
509.3
|
EBIT
1 |
237.3
|
266.3
|
248.8
|
1,605
|
883
|
361.2
|
Operating Margin
|
10.5%
|
10.64%
|
10.87%
|
33.93%
|
24.11%
|
13.09%
|
Earnings before Tax (EBT)
1 |
216.6
|
245.9
|
227.8
|
1,589
|
871.9
|
354
|
Net income
1 |
176.5
|
199.8
|
186.3
|
1,255
|
696.6
|
283.9
|
Net margin
|
7.81%
|
7.98%
|
8.13%
|
26.54%
|
19.02%
|
10.28%
|
EPS
2 |
0.3093
|
0.3502
|
0.3264
|
2.200
|
1.221
|
0.4974
|
Free Cash Flow
1 |
-56.37
|
83.06
|
7.251
|
948.7
|
183.2
|
19.39
|
FCF margin
|
-2.5%
|
3.32%
|
0.32%
|
20.06%
|
5%
|
0.7%
|
FCF Conversion (EBITDA)
|
-
|
20.02%
|
1.89%
|
54.81%
|
17.95%
|
3.81%
|
FCF Conversion (Net income)
|
-
|
41.57%
|
3.89%
|
75.58%
|
26.29%
|
6.83%
|
Dividend per Share
2 |
0.1200
|
0.1400
|
0.1250
|
0.5000
|
0.4500
|
0.2000
|
Announcement Date
|
19-02-25
|
20-02-27
|
21-02-22
|
22-02-24
|
23-02-27
|
24-02-19
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
293
|
247
|
311
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
876
|
877
|
697
|
Leverage (Debt/EBITDA)
|
0.7935
x
|
0.5946
x
|
0.8121
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-56.4
|
83.1
|
7.25
|
949
|
183
|
19.4
|
ROE (net income / shareholders' equity)
|
15.9%
|
16.2%
|
13.8%
|
63%
|
25%
|
9.42%
|
ROA (Net income/ Total Assets)
|
7.8%
|
7.93%
|
6.88%
|
33.7%
|
15%
|
6.16%
|
Assets
1 |
2,263
|
2,520
|
2,707
|
3,720
|
4,637
|
4,606
|
Book Value Per Share
2 |
2.050
|
2.270
|
2.460
|
4.540
|
5.260
|
5.310
|
Cash Flow per Share
2 |
0.2000
|
0.3300
|
0.3500
|
2.080
|
1.860
|
1.440
|
Capex
1 |
200
|
215
|
230
|
174
|
597
|
278
|
Capex / Sales
|
8.87%
|
8.59%
|
10.03%
|
3.69%
|
16.32%
|
10.08%
|
Announcement Date
|
19-02-25
|
20-02-27
|
21-02-22
|
22-02-24
|
23-02-27
|
24-02-19
|
|
1st Jan change
|
Capi.
|
---|
| +5.37% | 122M | | +20.68% | 85.55B | | -29.31% | 70.07B | | +9.23% | 28.95B | | -8.63% | 17.51B | | +2.14% | 17.39B | | +0.39% | 15.38B | | +6.47% | 13.4B | | +68.09% | 12.93B | | +6.43% | 12.77B |
Other Healthcare Facilities & Services
|